CAS No.499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE
CAS No.499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE
CAS No.499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE
+
  • CAS No.499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE
  • CAS No.499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE
  • CAS No.499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE

CAS No.499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE

Name: ARECAIDINE BUT-2-YNYL ESTER TOSYLATE CAS No. 499-04-7 MF:C7H11NO2 MW:141.17 Purity:98% Package: 10mg,25mg,50mg,100mg,250mg Worldwide Delivery

Categories:

Analytical Chemicals

Product introduction

Introduction and application of  CAS No. 499-04-7 | ARECAIDINE BUT-2-YNYL ESTER TOSYLATE

 

Synonyms:N-METHYL-1,2,5,6-TETRAHYDROPYRIDINE-3-CARBOXYLICACIDBUT-2-YNYLESTERTOSYLATE;1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxylicaci;1,2,5,6-Tetrahydro-1-methylpyridine-3-carboxylicacid;1-methyl-3,6-dihydro-2H-pyridine-5-carboxylicacid;1-Methyl-1,2,5,6-tetrahydropyridine-3-carboxylicacid;1,2,5,6-Tetrahydro-1-methyl-3-pyridinecarboxylicacidbut-2-ynylestertosylate;1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxylicacid;1,2,5,6-tetrahydro-1-methyl-nicotinicaci

 

Specification:

ITEMS

SPECIFICATION

CAS

499-04-7

MF

C7H11NO2

MW

141.17

Melting point

232°C

Boiling point

104-112℃

Density

1.166±0.06 g/cm3

Falsh point

115.1±25.9℃

Color

Crystallize from alcohol to obtain flaky crystals

Solubility

Soluble in DMSO (a little), methanol (a little)

Form

Solid

Storage condition

Sealed in dry,2-8°C

 

Pharmacological effects:

Arecoline lacks the typical parasympathomimetic effects of arecoline and can also affect the behavior of mice, reducing their autonomous activities and exploratory behavior. Studies have shown that arecoline and demethylarecoline have C-aminobutyric acid (GABA) reuptake inhibitor activity in rat brain slices. Another study using cat spinal cord slices pointed out that arecoline can enhance the inhibitory activity of GAGB and B-alanine, while desmethylarecoline can increase the inhibitory activity of GAGB without affecting the activity of glycine. This study also found that intravenous injection of arecoline had no effect on the activity of GAGB, which indicates that arecoline itself may not be able to pass through the blood-brain barrier to act, and the effect of arecoline on the central nervous system may be through transmitters other than GAGB. quality system functions.

 

Package and transportation :

Package: 10mg,25mg,50mg,100mg,250mg

Transportation: by courier/ by air/ by sea

Key words:

Related Products

Related Products

Inquiry

SUBMIT